Clinical manifestations, antibiotic susceptibility and molecular analysis of Mycobacterium kansasii isolates from a university hospital in Taiwan

Journal of Antimicrobial Chemotherapy

Volumn 64, Issue 3, 2009, Pages 511-514

  Wu, Ting Shu ^a,b   Leu, Hsieh Shong ^a   Chiu, Cheng Hsun ^a   Lee, Ming Hsun ^a   Chiang, Ping Cherng ^a   Wu, Tsu Lan ^a   Chia, Ju Hsin ^a   Su, Lin Hui ^a   Kuo, An Jing ^a   Lai, Hsin Chih ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Clonality; Multidrug resistance; Non tuberculous mycobacteria; Susceptibility tests

Indexed keywords

AMIKACIN; CIPROFLOXACIN; CLARITHROMYCIN; ETHAMBUTOL; ISONIAZID; MOXIFLOXACIN; RIFAMPICIN; STREPTOMYCIN; SULFAMETHOXAZOLE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLINICAL ARTICLE; CLINICAL FEATURE; COUGHING; DRUG EFFICACY; DRUG SENSITIVITY; DRUG TREATMENT FAILURE; DYSPNEA; FEMALE; HUMAN; IMMUNOCOMPROMISED PATIENT; LUNG INFECTION; MALE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM KANSASII; PHYLOGENY; SOFT TISSUE INFECTION; TAIWAN; UNIVERSITY HOSPITAL; WEIGHT REDUCTION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CLUSTER ANALYSIS; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENOTYPE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM KANSASII; RETROSPECTIVE STUDIES; TAIWAN; TREATMENT OUTCOME;

EID: 69049090937     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp238     Document Type: Article

References (13)

1. Runyon EH. Mycobacteria: An overview. Rev Infect Dis 1981; 3 819-21.
2. Griffith DE, Aksamit T, Brown-Elliott BA et al. An official ATS/ IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175: 367-416.
3. Shitrit D, Baum GL, Priess R et al. Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: Clinical features, drug susceptibility, and outcome. Chest 2006; 129: 771-6.
4. Telenti A, Marchesi F, Balz M et al. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol 1993; 31: 175-8.
5. National Committee for Clinical Laboratory Standards. Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes: Approved Standard M24-A. NCCLS, Wayne, PA, USA, 2003.
6. Zhang Y, Mann LB, Wilson RW et al. Molecular analysis of Mycobacterium kansasii isolates from the United States. J Clin Microbiol 2004; 42: 119-25.
7. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33 2233-9.
8. Lai CC, Lee LN, Ding LW et al. Emergence of disseminated infections due to nontuberculous mycobacteria in non-HIV-infected patients, including immunocompetent and immunocompromised patients in a university hospital in Taiwan. J Infect 2006; 53: 77-84.
9. Alcaide F, Calatayud L, Santín M et al. Comparative in vitro activities of linezolid, telithromycin, clarithromycin, levofloxacin, moxifloxacin, and four conventional antimycobacterial drugs against Mycobacterium kansasii. Antimicrob Agents Chemother 2004; 48: 4562-5.
10. da Silva Telles MA, Chimara E, Ferrazoli L et al. Mycobacterium kansasii: Antibiotic susceptibility and PCR-restriction analysis of clinical isolates. J Med Microbiol 2005; 54: 975-9.
11. Guna R, Muñoz C, Domínguez V et al. In vitro activity of linezolid, clarithromycin and moxifloxacin against clinical isolates of Mycobacterium kansasii. J Antimicrob Chemother 2005; 55: 950-3.
12. Picardeau M, Prod'Hom G, Raskine L et al. Genotypic characterization of five subspecies of Mycobacterium kansasii. J Clin Microbiol 1997; 35: 25-32.
13. Iinuma Y, Ichiyama S, Hasegawa Y et al. Large-restriction-fragment analysis of Mycobacterium kansasii genomic DNA and its application in molecular typing. J Clin Microbiol 1997; 35: 596-9.